| Authors: |
Burvenich IJG; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, Melbourne, Victoria, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Australia., Goh YW; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, Melbourne, Victoria, 3084, Australia., Guo N; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, Melbourne, Victoria, 3084, Australia., Gan HK; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, Melbourne, Victoria, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Australia., Rigopoulos A; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, Melbourne, Victoria, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Australia., Cao D; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, Melbourne, Victoria, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Australia., Liu Z; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, Melbourne, Victoria, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Australia., Ackermann U; School of Cancer Medicine, La Trobe University, Melbourne, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia.; Department of Medicine, University of Melbourne, Melbourne, Australia., Wichmann CW; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, Melbourne, Victoria, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Australia., McDonald AF; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, Melbourne, Victoria, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Australia., Huynh N; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, Melbourne, Victoria, 3084, Australia., O'Keefe GJ; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia.; Department of Medicine, University of Melbourne, Melbourne, Australia., Gong SJ; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia.; School of Engineering and Mathematical Sciences, La Trobe University, Melbourne, Australia., Scott FE; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, Melbourne, Victoria, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Australia., Li L; EMD Serono Research & Development Institute, Inc., a business of Merck KGaA, Darmstadt, Germany, Billerica, MA, USA., Geng W; EMD Serono Research & Development Institute, Inc., a business of Merck KGaA, Darmstadt, Germany, Billerica, MA, USA., Zutshi A; EMD Serono Research & Development Institute, Inc., a business of Merck KGaA, Darmstadt, Germany, Billerica, MA, USA., Lan Y; EMD Serono Research & Development Institute, Inc., a business of Merck KGaA, Darmstadt, Germany, Billerica, MA, USA., Scott AM; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, Melbourne, Victoria, 3084, Australia. andrew.scott@onjcri.org.au.; School of Cancer Medicine, La Trobe University, Melbourne, Australia. andrew.scott@onjcri.org.au.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia. andrew.scott@onjcri.org.au.; Department of Medicine, University of Melbourne, Melbourne, Australia. andrew.scott@onjcri.org.au. |
